↓ Skip to main content

Drug costs in the management of metastatic castration-resistant prostate cancer in Canada

Overview of attention for article published in BMC Health Services Research, June 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Drug costs in the management of metastatic castration-resistant prostate cancer in Canada
Published in
BMC Health Services Research, June 2014
DOI 10.1186/1472-6963-14-252
Pubmed ID
Authors

Alice Dragomir, Daniela Dinea, Marie Vanhuyse, Fabio L Cury, Armen G Aprikian

Abstract

For Canadian men, prostate cancer (PCa) is the most common cancer and the 3rd leading cause of cancer mortality. Men dying of PCa do so after failing castration. The management of metastatic castration-resistant prostate cancer (mCRPC) is complex and the associated drug treatments are increasingly costly. The objective of this study was to estimate the cost of drug treatments over the mCRPC period, in the context of the latest evidence-based approaches.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 2%
Unknown 44 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 22%
Researcher 9 20%
Other 6 13%
Student > Ph. D. Student 6 13%
Student > Postgraduate 4 9%
Other 4 9%
Unknown 6 13%
Readers by discipline Count As %
Medicine and Dentistry 15 33%
Economics, Econometrics and Finance 4 9%
Agricultural and Biological Sciences 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Mathematics 2 4%
Other 5 11%
Unknown 12 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2014.
All research outputs
#2,317,488
of 5,036,385 outputs
Outputs from BMC Health Services Research
#1,271
of 2,240 outputs
Outputs of similar age
#50,981
of 124,162 outputs
Outputs of similar age from BMC Health Services Research
#75
of 121 outputs
Altmetric has tracked 5,036,385 research outputs across all sources so far. This one has received more attention than most of these and is in the 51st percentile.
So far Altmetric has tracked 2,240 research outputs from this source. They receive a mean Attention Score of 4.6. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 124,162 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.